Universe Pharmaceuticals (UPC) Stock Price, News & Analysis

Company Overview

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is based in Ji'An, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.

Key Stats

• Today's Range: $4.51 to $5.57
• 50-Day Range: $3.52 to $21.00
• 52-Week Range: $3.20 to $2,592.00
• Volume: 64,720 shs
• Average Volume: 89,608 shs
• Market Capitalization: $210,270.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

UPC Stock Analysis - Frequently Asked Questions

How have UPC shares performed this year?

Universe Pharmaceuticals' stock was trading at $24.40 at the beginning of the year. Since then, UPC shares have decreased by 80.0% and is now trading at $4.89.
View the best growth stocks for 2025 here.

When did Universe Pharmaceuticals' stock split?

Universe Pharmaceuticals's stock reverse split before market open on Wednesday, November 13th 2024. The 1-15 reverse split was announced on Wednesday, November 13th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, November 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

When did Universe Pharmaceuticals IPO?

Universe Pharmaceuticals (UPC) raised $30 million in an initial public offering (IPO) on Tuesday, March 23rd 2021. The company issued 5,000,000 shares at $5.00-$7.00 per share. Univest Securities, LLC acted as the underwriter for the IPO.

Who are Universe Pharmaceuticals' major shareholders?

Universe Pharmaceuticals' top institutional investors include Anson Funds Management LP (13.40%).

How do I buy shares of Universe Pharmaceuticals?

Shares of UPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Universe Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Universe Pharmaceuticals investors own include NVIDIA (NVDA), Adobe (ADBE), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), e.l.f. Beauty (ELF) and General Electric (GE).

Company Calendar

• Today: 3/29/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NYSE:UPC
• CIK: 1809616
• Web: www.dzrzy.com
• Phone: 86-079-6840-3309
• Fax: N/A
• Employees: 220
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $26.73 million
• Price / Sales: 0.01
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $163.50 per share
• Price / Book: 0.03

Miscellaneous

• Outstanding Shares: 43,000
• Free Float: 731,000
• Market Cap: $210,270.00
• Optionable: Not Optionable
• Beta: 1.55